Views | |
---|---|
Commentary to the article : "rivaroxaban in secondary cardiogenic stroke prevention: two-year single-centre experience based on follow-up of 209 patients" | 88 |
stycznia 2022 | lutego 2022 | marca 2022 | kwietnia 2022 | maja 2022 | czerwca 2022 | lipca 2022 | |
---|---|---|---|---|---|---|---|
Commentary to the article : "rivaroxaban in secondary cardiogenic stroke prevention: two-year single-centre experience based on follow-up of 209 patients" | 1 | 2 | 0 | 1 | 1 | 0 | 0 |
Views | |
---|---|
undas_commentary_to_the_article_rivaroxaban_in_secondary_cardiogenic_stroke_prevention_2016.pdf | 119 |
undas_commentary_to_the_article_rivaroxaban_in_secondary_cardiogenic_stroke_prevention_2016.odt | 5 |
Views | |
---|---|
United States | 57 |
Poland | 7 |
Germany | 6 |
Vietnam | 3 |
Finland | 2 |
Bulgaria | 1 |
China | 1 |
Sweden | 1 |
Views | |
---|---|
Ashburn | 41 |
Polska | 6 |
Hanoi | 3 |
Des Moines | 2 |
Fairfield | 2 |
Helsinki | 2 |
Ann Arbor | 1 |
Beijing | 1 |
Cambridge | 1 |
Houston | 1 |